Results 131 to 140 of about 181,938 (338)

MOESM2 of Low toxicity and favorable clinical and quality of life impact after non-myeloablative autologous hematopoietic stem cell transplant in Crohnâ s disease

, 2017
Additional file 2. Complications following autologous hematopoietic stem cell transplantation.
Ruiz, Milton, Kaiser, Roberto, Luiz Quadros, Piron-Ruiz, Lilian, PeĂąa-Arciniegas, Tatiana, Mikaell Faria, Siqueira, Rubens, Pirozzi, Flavio, Kaiser, Fernanda, Burt, Richard   +9 more
openaire   +1 more source

Engineered Probiotics: The Next‐Generation Therapeutics to Combat Antibiotic‐Resistant Bacterial Infections

Food Frontiers, EarlyView.
Engineered probiotics secretes fusion proteins which potentially neutralized the toxins secreted by other microbial communities. ABSTRACT On a global scale, the escalating burden of infectious diseases, predominantly attributed to bacterial pathogens, especially drug‐resistant strains, has progressed into a critical concern for clinical management and ...
Indu Singh, Raz Abdulqadir, Indira Kumari Verma, Yashika Awasthi, Arun Ratn, Juhi Sharma, Manmeet Rawat, Megh Singh Dhakad, Jasbir Dalal, Yash Gupta, Bhisham Narayan Singh, Divakar Sharma   +11 more
wiley   +1 more source

Switching from reference infliximab to CT-P13 in patients with inflammatory bowel disease: 12 months results [PDF]

, 2017
Background: Biological agents, such as infliximab, have transformed the outcomes of patients with immune-mediated inflammatory diseases. The advent of biosimilar treatment options such as CT-P13 promises to improve the availability of biological therapy,
Argüelles Arias, Federico, Castro Laria, Luisa, Guerra Veloz, María Fernanda, Maldonado Pérez, Belén, Merino Bohórquez, Vicente, Perea Amarillo, Raúl, Romero Gómez, Manuel, Vilches Arenas, Ángel   +7 more
core  

Additional file 4: of Circulating cathelicidin levels correlate with mucosal disease activity in ulcerative colitis, risk of intestinal stricture in Crohnâ s disease, and clinical prognosis in inflammatory bowel disease

, 2017
Figure S4. Data analysis of CD clinical activity. Prevalence, sensitivity, specificity, PPV, NPV, and AUC values of ROC curves of LL-37 test alone, CRP test alone, and both in indicating (A) CD clinical remission and (B) moderate or severe CD clinical activity.
Tran, Diana, Jiani Wang, Ha, Christina, Ho, Wendy, S. Mattai, Oikonomopoulos, Angelos, Weiss, Guy, Lacey, Precious, Cheng, Michelle, Shieh, Christine, Mussatto, Caroline, Ho, Samantha, Hommes, Daniel, Hon Koon   +13 more
openaire   +1 more source

A Mucoadhesive Hydrogel for Precise Resveratrol Delivery in the Management of Inflammatory Bowel Disease

Food Frontiers, EarlyView.
CMTR‐Gel targeting to the inflamed mucosa by electrostatic interactions. ABSTRACT Natural drug‐food homology compounds have vast therapeutic potential, particularly for inflammatory bowel disease (IBD), but their poor water solubility, instability, and limited mucosal availability hinder their clinical translation.
Wenqiu Xu, Xiaojia Lv, Jilun Ye, Ying Li, Hua Yu, Chenyang Li, Haiqiang Wu, Wei Xiong   +7 more
wiley   +1 more source

A Rare Manifestation of Crohn's Disease: Sinonasal Granulomatosis. Report of a Case and Review of Literature

European Journal of Case Reports in Internal Medicine, 2014
Crohn’s disease is a granulomatous inflammatory bowel disease. Its pathologic findings include non-contiguous chronic inflammation and non-caseating granulomas, sometimes with extra-intestinal localizations.
Lilia Baili, Imène Rachdi, Fatma Daoud, Zohra Aydi, Basma Ben Dhaou, Samir Kochbati, Fatma Boussema   +6 more
doaj   +1 more source

Additional file 3: of High-intensity interval training and moderate-intensity continuous training in adults with Crohnâ s disease: a pilot randomised controlled trial

, 2019
Implications and proposed changes for the full-scale trial. (DOCX 16 kb)
Tew, Garry, Leighton, Dean, Carpenter, Roger, Anderson, Simon, Langmead, Louise, Ramage, John, Faulkner, James, Coleman, Elizabeth, Fairhurst, Caroline, Seed, Michael, Bottoms, Lindsay   +10 more
openaire   +1 more source

Additional file 2: of High-intensity interval training and moderate-intensity continuous training in adults with Crohnâ s disease: a pilot randomised controlled trial

, 2019
Summary of recruitment survey data. (DOCX 12 kb)
Tew, Garry, Leighton, Dean, Carpenter, Roger, Anderson, Simon, Langmead, Louise, Ramage, John, Faulkner, James, Coleman, Elizabeth, Fairhurst, Caroline, Seed, Michael, Bottoms, Lindsay   +10 more
openaire   +1 more source

Steroid-Dependent Crohn’s Disease

Canadian Journal of Gastroenterology, 2000
Placebo controlled trials have demonstrated that a tapering course of corticosteroids is an effective therapy for active Crohn’s disease. A populationbased study of 109 patients with Crohn’s disease undergoing their first course of corticosteroids showed
William J Sandborn
doaj   +1 more source

Anti-tumour necrosis factor therapy in Crohn’s disease: where are we now? [PDF]

, 2002
Sander J. H. van Deventer
openalex   +1 more source